NOF CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,122 JPY | -1.00% |
|
+2.54% | -9.16% |
| Sales 2024 * | 222B 1.45B | Sales 2025 * | 237B 1.55B | Capitalization | 507B 3.31B |
|---|---|---|---|---|---|
| Net income 2024 * | 31.93B 209M | Net income 2025 * | 34.07B 223M | EV / Sales 2024 * | 1.91 x |
| Net cash position 2024 * | 83.6B 546M | Net cash position 2025 * | 81.6B 533M | EV / Sales 2025 * | 1.79 x |
| P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
15
x | Employees | 3,818 |
| Yield 2024 * |
1.83% | Yield 2025 * |
1.93% | Free-Float | 87.53% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.00% | ||
| 1 week | +2.54% | ||
| Current month | -0.07% | ||
| 1 month | +3.87% | ||
| 3 months | -6.43% | ||
| 6 months | -5.08% | ||
| Current year | -9.16% |
1 week
2 068.50
2 155.00
1 month
2 001.002 171.50
Current year
2 001.002 454.67
1 year
1 920.002 454.67
3 years
1 473.332 454.67
5 years
932.332 454.67
10 years
423.332 454.67
| Managers | Title | Age | Since |
|---|---|---|---|
Takeo Miyaji
PSD | President | 68 | 80-03-31 |
Kazumi Yamauchi
BRD | Director/Board Member | - | - |
Masanobu Miyo
BRD | Director/Board Member | 63 | 85-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shingo Unami
BRD | Director/Board Member | - | - |
Kazuhito Maeda
BRD | Director/Board Member | 67 | 81-03-31 |
Takeo Miyaji
PSD | President | 68 | 80-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.92% | 8 M€ | +6.91% | ||
| 0.17% | 4 M€ | +16.67% | ||
| 0.15% | 60 M€ | +16.25% | ||
| 0.09% | 10,207 M€ | +16.36% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 2,122 | -1.00% | 209,500 |
| 24-05-01 | 2,143 | +0.94% | 321,200 |
| 24-04-30 | 2,123 | +1.60% | 444,400 |
| 24-04-26 | 2,090 | +0.99% | 405,300 |
| 24-04-25 | 2,069 | -0.77% | 278,600 |
Delayed Quote Japan Exchange, May 02, 2024 at 02:00 am EDT
More quotes
NOF CORPORATION is mainly engaged in the functional chemical products business, life science business and others. The Company operates in three segments. The Functional Chemical segment is engaged in the manufacture and sale of fatty acids, fatty acid derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, petroleum chemicals, functional polymers, functional films, electronic materials and special rust prevention agents, as well as the rust prevention processing. The Life Science segment is engaged in the manufacture and sale of drug formulation materials for drug delivery systems (DDSs), edible oils and fats and health food products, among others. The Chemical segment is engaged in the manufacture and sale of industrial explosives, defense-related items, space-related products. The Company also operates in transportation business and real estate business.
Sector
Commodity Chemicals
Calendar
2024-05-08
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2,122
JPY
Average target price
2,833
JPY
Spread / Average Target
+33.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.16% | 3.3B | |
| +2.56% | 101B | |
| -1.20% | 65.99B | |
| +47.62% | 41.98B | |
| +15.99% | 38.65B | |
| +4.25% | 32.16B | |
| +8.78% | 19.21B | |
| +12.32% | 16.76B | |
| +17.69% | 15.07B | |
| +8.31% | 14.82B |
- Stock Market
- Equities
- 4403 Stock
